Chen et al. provided evidence supporting the notion that the activation of p53 and p21 may effectively suppress the expression of CDKs, E2 Fs, and other factors that facilitate DNA replication during the G1/S phase arrest in bladder cancer [38]. The gene discussed is TP53; the disease is urinary bladder cancer.